Ana Luz Cano-Díaz

8PUBLICATIONS
13CO-AUTHORS
Haematological tumoursImmunogenetics (incl. genetic immunology)Gene and molecular therapyMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 18, 2025
Effectiveness and safety of dolutegravir/lamivudine/abacavir versus bictegravir/emtricitabine/tenofovir alafenamide as first-line regimens in real-world settings (MICTLAN study).

José Antonio Mata-Marín, Mara Soraya Rodríguez-Evaristo, Ana Luz Cano-Díaz

|Aug 28, 2025
Prevalence and Associated Factors for HPV in People Living with HIV: Are INSTIs Protective Against HPV-16? The GAIA Study.

Omar Hernández-López, Brenda Clara González-Contreras, Ana Luz Cano-Díaz

|Nov 27, 2024
Effectiveness of Direct Antiviral Agents in People with HCV-Monoinfection Compared to HCV/HIV Coinfection in a Real Life Setting.

Cristina Guadalupe Román López, Salma Triana González, Ana Luz Cano Díaz

Pageof 2